Patents by Inventor William BOCK

William BOCK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12637414
    Abstract: The present disclosure relates to heterocyclic compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis.
    Type: Grant
    Filed: June 3, 2022
    Date of Patent: May 26, 2026
    Assignee: Genzyme Corporation
    Inventors: Junkai Liao, Mark Munson, Zhongli Gao, Gregory Hurlbut, Hans Peter Nestler, Ingrid Mechin, Joseph Kim, Martin Smrcina, Nina Ma, Ronghua Li, Ryan Hartung, William Bock, Bertrand Vivet
  • Patent number: 12630498
    Abstract: The present disclosure relates to substituted aryl amide compounds, according to Formula (I): pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis.
    Type: Grant
    Filed: June 3, 2022
    Date of Patent: May 19, 2026
    Assignee: Genzyme Corporation
    Inventors: Junkai Liao, Mark Munson, Zhongli Gao, Gregory Hurlbut, Hans Peter Nestler, Helen Yeoman, Martin Smrcina, Ronghua Li, Ryan Hartung, William Wire, Bertrand Vivet, Nina Ma, William Bock, Aleksandra Weichsel, Andrew Scholte
  • Patent number: 12630521
    Abstract: The present disclosure relates to heterocyclic compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis.
    Type: Grant
    Filed: June 3, 2022
    Date of Patent: May 19, 2026
    Assignee: Genzyme Corporation
    Inventors: Junkai Liao, Mark Munson, Zhongli Gao, Gregory Hurlbut, Hans Peter Nestler, Ingrid Mechin, Martin Smrcina, Ronghua Li, Ryan Hartung, William Bock, Bertrand Vivet, Andrew Scholte
  • Patent number: 12613878
    Abstract: Embodiments of the present invention provide a system for dynamically enabling data connections between large datasets stored in a networked system. The system is configured for allowing users to select at least two datasets from one or more datasets associated with an entity, receiving a selection of a first dataset of the at least two datasets from the users, automatically presenting a set of datasets associated with the first dataset to the users, receiving a selection of a second dataset of the at least two datasets from the set of datasets presented to the users, receiving one or more data connections between at least a first element of the first dataset and at least a second element of the second dataset, and enabling the one or more data connections between at least the first element of the first dataset and at least the second element of the second dataset.
    Type: Grant
    Filed: September 3, 2024
    Date of Patent: April 28, 2026
    Assignee: BANK OF AMERICA CORPORATION
    Inventors: John Kling, William Bock, Scott Desmond, Charles Dudley, Jordan Lasher, Sudheer Vajrala, Jason Yeung
  • Publication number: 20260064705
    Abstract: Embodiments of the present invention provide a system for dynamically enabling data connections between large datasets stored in a networked system. The system is configured for allowing users to select at least two datasets from one or more datasets associated with an entity, receiving a selection of a first dataset of the at least two datasets from the users, automatically presenting a set of datasets associated with the first dataset to the users, receiving a selection of a second dataset of the at least two datasets from the set of datasets presented to the users, receiving one or more data connections between at least a first element of the first dataset and at least a second element of the second dataset, and enabling the one or more data connections between at least the first element of the first dataset and at least the second element of the second dataset.
    Type: Application
    Filed: September 3, 2024
    Publication date: March 5, 2026
    Applicant: BANK OF AMERICA CORPORATION
    Inventors: John Kling, William Bock, Scott Desmond, Charles Dudley, Jordan Lasher, Sudheer Vajrala, Jason Yeung
  • Publication number: 20230159439
    Abstract: The present disclosure relates to heterocyclic compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis.
    Type: Application
    Filed: June 3, 2022
    Publication date: May 25, 2023
    Inventors: Junkai Liao, Mark Munson, Zhongli Gao, Gregory Hurlbut, Hans Peter Nestler, Ingrid Mechin, Joseph Kim, Martin Smrcina, Nina Ma, Ronghua Li, Ryan Hartung, William Bock, Bertrand Vivet
  • Publication number: 20230147360
    Abstract: The present disclosure relates to heterocyclic compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis.
    Type: Application
    Filed: June 3, 2022
    Publication date: May 11, 2023
    Inventors: Junkai Liao, Mark Munson, Zhongli Gao, Gregory Hurlbut, Hans Peter Nestler, Ingrid Mechin, Martin Smrcina, Ronghua Li, Ryan Hartung, William Bock, Bertrand Vivet, Andrew Scholte
  • Patent number: 10437960
    Abstract: A method, system, computer program product and apparatus related to managing and disseminating information in a health care facility is disclosed. The system may comprise a plurality of input devices, a processor connected to the input devices and a plurality of electronic output devices connected to the processor. The output devices may include a master patient information display, an electronic patient room information display, a master precaution display, a patient hourly rounding display and an individual room precaution display. The method may comprises receiving from at least one input device data associated with a plurality of patients, and displaying for each patient the information, based on the data received, that is associated with each patient, and then updating on each output device the information when it changes.
    Type: Grant
    Filed: August 26, 2015
    Date of Patent: October 8, 2019
    Assignee: SHELDON INVESTMENT GROUP, INC.
    Inventors: Daniel Sheldon, Sonne DeVries, Clare Cooke, Dennis Bednar, William Bock, Randall Karlsen, Noel Wolbing, Saad Yusuf
  • Publication number: 20150363556
    Abstract: A method, system, computer program product and apparatus related to managing and disseminating information in a health care facility is disclosed. The system may comprise a plurality of input devices, a processor connected to the input devices and a plurality of electronic output devices connected to the processor. The output devices may include a master patient information display, an electronic patient room information display, a master precaution display, a patient hourly rounding display and an individual room precaution display. The method may comprises receiving from at least one input device data associated with a plurality of patients, and displaying for each patient the information, based on the data received, that is associated with each patient, and then updating on each output device the information when it changes.
    Type: Application
    Filed: August 26, 2015
    Publication date: December 17, 2015
    Inventors: Daniel Sheldon, Sonne DeVries, Clare Cooke, Dennis Badnar, William Bock, Randall Karlsen, Noel Wolbing, Saad Yusuf
  • Patent number: 8501981
    Abstract: The invention relates to compounds of the formula I in which R1, R2, X, A, B, Z and Y1 to Y4 have the meanings indicated in the claims, and/or a pharmaceutically acceptable salt and/or a prodrug thereof. Because of their properties as inhibitors of chemokine receptors, especially as CXCR2 inhibitors, the compounds of the formula I and the pharmaceutically acceptable salts and prodrugs thereof are suitable for the prevention and treatment of chemokine mediated diseases.
    Type: Grant
    Filed: December 17, 2008
    Date of Patent: August 6, 2013
    Assignee: SANOFI
    Inventors: Stephanie Hachtel, Juergen Dedio, Elisabeth DeFossa, Sven Grueneberg, Holger Heitsch, William Bock, Charlie Chen, Raymond Kosley, Chung-Yi Kung, Marcel Patek, Rosy Sher, Stephen Shimshock, Aleksandra Weichsel
  • Publication number: 20120078661
    Abstract: A method, system, computer program product and apparatus related to managing and disseminating information in a health care facility is disclosed. The system may comprise a plurality of input devices, a processor connected to the input devices and a plurality of electronic output devices connected to the processor. The output devices may include a master patient information display, an electronic patient room information display, a master precaution display, a patient hourly rounding display and an individual room precaution display. The method may comprise receiving from at least one input device data associated with a plurality of patients, and displaying for each patient the information, based on the data received, that is associated with each patient, and then updating on each output device the information when it changes.
    Type: Application
    Filed: December 30, 2010
    Publication date: March 29, 2012
    Applicant: Scan Am Company
    Inventors: Daniel Sheldon, Sonne DeVries, Clare Cooke, Dennis Bednar, William Bock, Randall Karlsen, Noel Wolbing, Saad Yusuf
  • Publication number: 20090227625
    Abstract: The invention relates to compounds of the formula I in which R1, R2, X, A, B, Z and Y1 to Y4 have the meanings indicated in the claims, and/or a pharmaceutically acceptable salt and/or a prodrug thereof. Because of their properties as inhibitors of chemokine receptors, especially as CXCR2 inhibitors, the compounds of the formula I and the pharmaceutically acceptable salts and prodrugs thereof are suitable for the prevention and treatment of chemokine mediated diseases.
    Type: Application
    Filed: December 17, 2008
    Publication date: September 10, 2009
    Applicant: sanofi-aventis
    Inventors: Stephanie HACHTEL, Juergen DEDIO, Elisabeth DeFOSSA, Sven GRUENEBERG, Holger HEITSCH, William BOCK, Charlie CHEN, Raymond KOSLEY, Chung-Yi KUNG, Marcel PATEK, Rosy SHER, Stephen SHIMSHOCK, Aleksandra WEICHSEL